Tumor development often requires cellular adaptation to a unique, high metabolic state; however, the molecular mechanisms that drive such metabolic changes in TFE3–rearranged renal cell carcinoma (TFE3‐RCC) remain poorly understood. Here, TFE3 is linked to hereditary clear cell renal cell carcinoma.